Liabilities / Assets
25th percentile
Higher debt load relative to assets than 25% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.02x
Liabilities / Revenue
26th percentile
Higher debt load relative to revenue than 26% of similar nonprofits.
Net Margin
66th percentile
Higher net margin than 66% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
52nd percentile
Faster asset growth than 52% of similar nonprofits.
Revenue Growth
9th percentile
Faster revenue growth than 9% of similar nonprofits.
Balance Sheet
Assets
Up$3,107,205
Up $198,698 (+6.8%) from 2022
Net Assets
Up$3,029,767
Up $181,301 (+6.4%) from 2022
Liabilities
Up$77,438
Up $17,397 (+29%) from 2022
Revenue And Expenses
Revenue
Down$1,885,745
Down $312,406 (-14%) from 2022
Expenses
Up$1,706,594
Up $247,166 (+17%) from 2022
Net Income
Down$179,151
Down $559,572 (-76%) from 2022
Historical Trend
Filing Detail Status
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2023 to Dec 31, 2023
Mission and Program Overview
Mission
Bioflorida is the voice of floridas life sciences industry, representing nearly 5,500 establishments and research organizations in the biotechnology, pharmaceuticals, medical devices/diagnostics and bioagriculture sectors that collectively employ nearly 80,000 floridians.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2023 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $3,107,205
- Liabilities
- $77,438
- Net assets
- $3,029,767
- Revenue
- $1,885,745
- Expenses
- $1,706,594
- Net income
- $179,151